New study tackles weight stigma in teens to boost weight loss success
NCT ID NCT06864208
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests whether a 4-week program addressing weight stigma and self-blame can help teens (ages 13-17) better manage their weight. Participants are randomly assigned to either the stigma-focused program or a general health education session, followed by a 16-week weight management program. Researchers will measure changes in self-stigma, stress hormones, inflammation, and eating behaviors over 20 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 64 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Speak English; * 13-17 years of age; * BMI at or above \>95th%ile for age and sex; * Have at least one caregiver available to provide consent and participate in sessions; * Agree to study participation; Exclusion Criteria: * Cognitive impairment or developmental delay impairing participation in a group setting; * Current participation in a weight management program or recent weight loss of 5% of body weight or more; * Medical condition known to impact weight or that would otherwise prevent participation; * Current use of glucagon-like peptide-1 (GLP-1) receptor agonists;
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Biological markers of inflammation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Miriam Hospital
Providence, Rhode Island, 02903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?